Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q2 FY20 results · Jul–Sep 2019
Caplin Point Laboratories reported revenue from operations of ₹133.26 crore (up 1.5% from Q2 FY19) and net profit of ₹39.79 crore (up 34.3% from Q2 FY19) for Q2 FY20 (Jul–Sep 2019), on a standalone basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 133.26 | 131.24 | +1.5% | 140.27 | −5.0% |
| Other income | 4.58 | 6.67 | −31.3% | 19.94 | −77.0% |
| Total income | 137.84 | 137.91 | −0.0% | 160.21 | −14.0% |
| Profit before tax | 52.69 | 43.32 | +21.6% | 74.03 | −28.8% |
| Net profit for the period | 39.79 | 29.62 | +34.3% | 60.11 | −33.8% |
| EPS, basic (₹) | 5.26 | 3.95 | +33.2% | 7.95 | −33.8% |
| Net margin (%) | 29.9 | 22.6 | 42.9 |
Standalone
- Filed with BSE
- 01 Nov 2019, 16:00 IST
- Board meeting
- 30 Oct 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE